SCHEMBL1074482

SCHEMBL1074482

COc1cccc(CCOc2cccc(/C=C3\CCN(C(=O)Nc4ccc(OC)nc4)CC3C)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
FAAH O00519 4/20 0.39
GRIN2B Q13224 2/20 0.39
CCR3 P51677 3/20 0.38
OGA O60502 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
GFER P55789 1/20 0.38
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074485 1.00 ALDH1A1 (0.46) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1037912 0.95 CYP3A4 (0.44) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1037911 0.95 CYP3A4 (0.44) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1040202 0.94 CYP3A4 (0.44) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1040203 0.94 CYP3A4 (0.44) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1963541 0.93 CYP3A4 (0.46) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1963539 0.93 CYP3A4 (0.46) ALDH1A1LMNAMAPTCYP3A4CYP2D6
SCHEMBL1038632 0.93 CYP3A4 (0.47) ALDH1A1CYP3A4CYP2D6FAAHGRIN2B
SCHEMBL1038631 0.93 CYP3A4 (0.47) ALDH1A1CYP3A4CYP2D6FAAHGRIN2B
SCHEMBL1040016 0.92 CYP3A4 (0.46) ALDH1A1LMNAMAPTCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144159-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC 2011-06-16 US disclosed
EP-2276735-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS Pfizer Inc. (US) 2011-01-26 EP disclosed
WO-2009127944-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC. (US) 2009-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144159-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS FAAH, FAAH2, PAH ALDH1A1 586/4885LMNA 2425/4885MAPT 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.